SENS peer analysis
Senseonics (SENS) against its competitors: price, today's move, 1-year return and market value side by side.
SENS and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| BBNX Beta Bionics | $16.49 | -2.71% | -37.30% | $896.51M |
| DXCM DexCom | $79.44 | -2.01% | 44.44% | $29.63B |
| GCTK GlucoTrack | $1.39 | -32.20% | -99.28% | $1.65M |
| MMED MiniMed | $17.40 | -2.68% | – | $4.90B |
| PFSA Profusa | $0.56 | 2.51% | -99.96% | $341.34K |
| PODD Insulet | $147.70 | -1.41% | -53.82% | $10.25B |
| TNDM Tandem Diabetes | $18.46 | 1.60% | 13.53% | $1.29B |
| SENS Senseonics | $11.43 | 16.63% | 90.18% | $604.35M |
- SENS's peers: BBNX (Beta Bionics), DXCM (DexCom), GCTK (GlucoTrack), MMED (MiniMed), PFSA (Profusa), PODD (Insulet), TNDM (Tandem Diabetes).
Updated 2026-11-10 16:50 UTC